{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:03:20Z","timestamp":1791216200031,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,21]]},"DOI":"10.1093\/eurheartj\/ehs368","type":"journal-article","created":{"date-parts":[[2012,11,9]],"date-time":"2012-11-09T22:18:19Z","timestamp":1352499499000},"page":"1204-1214","source":"Crossref","is-referenced-by-count":170,"title":["Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis"],"prefix":"10.1093","volume":"34","author":[{"given":"Dharam J.","family":"Kumbhani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Gabriel","family":"Steg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim A.","family":"Eagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Sidney C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Magnus","family":"Ohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"Bakris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd S.","family":"Perlstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Kinlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,11,9]]},"reference":[{"key":"key\n\t\t\t\t20170626080429_EHS368C1","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","article-title":"Heart disease and stroke statistics\u20142011 update: a report from the American Heart Association","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170626080429_EHS368C2","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/jama.289.18.2363","article-title":"Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States","volume":"289","author":"Wolf-Maier","year":"2003","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170626080429_EHS368C3","volume-title":"Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks","author":"World Health Organization","year":"2009"},{"key":"key\n\t\t\t\t20170626080429_EHS368C4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0195-668X(02)00797-2","article-title":"Outcome beyond blood pressure control?","volume":"24","author":"Staessen","year":"2003","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170626080429_EHS368C5","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170626080429_EHS368C6","first-page":"1462","article-title":"The task force for the management of arterial hypertension of the European Society of H, The task force for the management of arterial hypertension of the European Society of C. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"28","author":"Mancia","year":"2007","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170626080429_EHS368C7","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.jacc.2008.08.036","article-title":"Resistant hypertension: an overview of evaluation and treatment","volume":"52","author":"Sarafidis","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170626080429_EHS368C8","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170626080429_EHS368C9","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","article-title":"Prevalence of resistant hypertension in the United States, 2003\u20138","volume":"57","author":"Persell","year":"2011","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170626080429_EHS368C10","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.110.168948","article-title":"Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring","volume":"57","author":"de la Sierra","year":"2011","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170626080429_EHS368C11","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/CIRCULATIONAHA.111.030189","article-title":"Uncontrolled and apparent treatment resistant hypertension in the United States, 1988\u20132008","volume":"124","author":"Egan","year":"2011","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170626080429_EHS368C12","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","article-title":"Incidence and prognosis of resistant hypertension in hypertensive patients","volume":"125","author":"Daugherty","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170626080429_EHS368C13","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170626080429_EHS368C14","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1097\/00004872-200310000-00009","article-title":"Blood pressure is insufficiently controlled in European patients with established coronary heart disease","volume":"21","author":"Boersma","year":"2003","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20170626080429_EHS368C15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170626080429_EHS368C16","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1093\/eurheartj\/ehp355","article-title":"Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry","volume":"30","author":"Alberts","year":"2009","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170626080429_EHS368C17","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170626080429_EHS368C18","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ahj.2005.11.004","article-title":"The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design","volume":"151","author":"Ohman","year":"2006","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170626080429_EHS368C19","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170626080429_EHS368C20","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/eurheartj\/ehr003","article-title":"Renal function and target organ damage in hypertension","volume":"32","author":"Ruilope","year":"2011","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170626080429_EHS368C21","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.amjhyper.2005.05.014","article-title":"Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension","volume":"18","author":"Pierdomenico","year":"2005","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t20170626080429_EHS368C22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jacc.2011.06.008","article-title":"Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial","volume":"58","author":"Bisognano","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170626080429_EHS368C23","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study","volume":"373","author":"Krum","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170626080429_EHS368C24","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial","volume":"376","author":"Esler","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170626080429_EHS368C25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11906-010-0119-1","article-title":"New therapeutic approaches to resistant hypertension","volume":"12","author":"Schlaich","year":"2010","journal-title":"Curr Hypertens Rep"},{"key":"key\n\t\t\t\t20170626080429_EHS368C26","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/clc.22008","article-title":"Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 trial","volume":"35","author":"Kandzari","year":"2012","journal-title":"Clin Cardiol"},{"key":"key\n\t\t\t\t20170626080429_EHS368C27","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jacc.2010.10.057","article-title":"Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. A meta-analysis","volume":"57","author":"Holland","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170626080429_EHS368C28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170626080429_EHS368C29","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","article-title":"Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document","volume":"27","author":"Mancia","year":"2009","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20170626080429_EHS368C30","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(08)60381-5","article-title":"Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study","volume":"371","author":"Tissot","year":"2008","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170626080429_EHS368C31","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(09)61500-2","article-title":"A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial","volume":"374","author":"Weber","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170626080429_EHS368C32","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1001\/jama.2010.743","article-title":"Advancing the care of cardiac patients using registry data: going where randomized clinical trials dare not","volume":"303","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170626080429_EHS368C33","first-page":"A15957","article-title":"Prospective assessment of the relationship between the use of evidence-based prevention therapies and long-term (4-year) outcomes in stable outpatients with established atherothrombotic disease: Insights from the international Reduction of Atherothrombosis for Continued Health (REACH) registry","volume":"124","author":"Kumbhani","year":"2011","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170626080429_EHS368C34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170626080429_EHS368C35","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ahj.2010.12.006","article-title":"Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials","volume":"161","author":"Kumbhani","year":"2011","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170626080429_EHS368C36","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/01.HYP.31.2.712","article-title":"Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study","volume":"31","author":"Redon","year":"1998","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170626080429_EHS368C37","first-page":"319","article-title":"Task force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring","volume":"4","author":"Staessen","year":"1999","journal-title":"Blood Press Monit"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/34\/16\/1204\/17894590\/ehs368.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T20:25:14Z","timestamp":1503433514000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/ehs368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,9]]},"references-count":37,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2012,11,9]]},"published-print":{"date-parts":[[2013,4,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehs368","relation":{},"ISSN":["1522-9645","0195-668X"],"issn-type":[{"value":"1522-9645","type":"electronic"},{"value":"0195-668X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11,9]]}}}